Drugs / 68Ga-PSMA-CYC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07056790 Comparator | May 2025 → Feb 2027 expected | prostate cancer | First Affiliated Hospital of Fujian Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-PSMA-CYC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07056790 ↗ |
| Modality | Diagnostic / imaging agent | “68Ga-PSMA-CYC PET/CT” NCT07056790 ↗ |